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Background. On the edge of the «Third Francophone Conference on the
Treatment of Opioid Addiction», the Neuchatel Institute of Health Law com-
pared regulations for opioid substitution treatment (OST) in Switzerland,
France, Canada, Belgium and Tunisia. Most standards described appear to be
linked to a historic repressive framework. Reference to the right to health as
defined by the Committee on Economic, Social and Cultural Rights (general
comment 14), appear to be absent or unclear. We present the rational for creat-
ing an interdisciplinary panel from the concerned countries, in order to
prepare recommendations about how a regulative system of OST should be
based on scientific evidence and right to health.
Method. Following a literature review identifying barriers to best practice
from an addiction medicine point of view, a DELFI technique will identify the
domains requiring removal or implementation of regulations, as a priority.
Results and Conclusion. Based on the report of comparative law cited above,
following areas need to be considered: access to care and free choice to treat-
ment; the articulation of different laws; conditions for authorisation; concerned
substances and products; personal conditions posed to patients and profes-
sionals; requirements and limitations surrounding substitution treatment itself;
the terms of ending or interruption; the protection of personal data.
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